America’s unfortunate backward step on vaccines
2025 has been a good year for immunisation science, but not in the US
Related reading
US vaccine overhaul unnerves investors as sceptics seize advisory posts
Vaccine businesses seen as valuable parts of pharma groups but government hostility could deter future developments
A test for global public health
The decline in funding for vaccinations poses a worldwide threat
As measles spreads, old vaccination canards do too
For as long as there have been vaccines, there has been passionate opposition to them
Measles surging again as vaccine rates drop, WHO warns
Immunisation has helped cut global cases by 71% since 2000 but progress is slowing
How US anti-vaxxers found they were not immune to pushback
Recent setbacks for the movement signal a potential turning point for the vaccine makers as the market picks up
US to speed up payments for new medical devices
Regulators hand industry a lobbying victory after fierce effort to get faster coverage for their products